Cargando…
Current colorectal cancer chemotherapy dosing limitations and novel assessments to personalize treatments
Autores principales: | Arafat, Yasser, Loft, Matthew, Cao, Ke, Reid, Fiona, Kosmider, Suzanne, Lee, Margret, Gibbs, Peter, Faragher, Ian G., Yeung, Justin M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827998/ https://www.ncbi.nlm.nih.gov/pubmed/36398349 http://dx.doi.org/10.1111/ans.18046 |
Ejemplares similares
-
Can AI-based body composition assessment outperform body surface area in predicting dose-limiting toxicities for colonic cancer patients on chemotherapy?
por: Cao, Ke, et al.
Publicado: (2023) -
The effect of smoking, obesity and diabetes on recurrence‐free and overall survival in patients with stage III colon cancer receiving adjuvant chemotherapy
por: Croese, Alex, et al.
Publicado: (2021) -
Biology and Clinical Implications of Fecal Occult Blood Test Screen-Detected Colorectal Cancer
por: Mendis, Shehara, et al.
Publicado: (2022) -
Implementation of an organ space infection prevention bundle reduces the rate of organ space infection after elective colorectal surgery
por: Faragher, Ian, et al.
Publicado: (2021) -
What Personalized Medicine Humans Need and Way to It ——also on the Practical Significance and Scientific Limitations of Precision Medicine
por: Yuan, Bing
Publicado: (2022)